RALGDS and neoplasm: The expression of mutant RAS glycine 12 to valine (G12V), promotes tumor initiation by activating different effectors, including Raf, phosphoinositide 3-kinase (PI3K), and Ras-like (Ral) guanine nucleotide exchange factor (RalGEF) [3].